This trial is completed!
Search for a recruiting clinical trial for your condition
You can access this
clinical trial
if you have
Anemia in Chronic Kidney Disease
and you are
between 18 and 75
years old
Phase
2
This is a second phase trial assessing
efficacy and side effects of the new treatment.
Show me locations

The purpose

The primary purpose of this study is to evaluate efficacy and safety of FG-4592 in the correction of anemia in non-dialysis chronic kidney disease patients.

Provided treatments

  • Drug: FG-4592
  • Drug: Placebo
Tris trial is registered with FDA with number: NCT01599507. The sponsor of the trial is FibroGen and it is looking for 91 volunteers for the current phase.
Official trial title:
A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Sequential Group, Dose Ranging Safety and Efficacy Study of FG 4592 in Non-dialysis Chronic Kidney Disease (CKD) Subjects With Anemia